New developments and strategies for success in dealing with FDA, OIG, SEC, EMEA, and more.
Jun 3, 2009 By:George Koroneos, Online Content & News Editor
The feds green lit a task force charged with easing the flow of communication between FDA, pharma companies, and the general public. While the team is being billed as a task force for transparency, it?s still unclear what is being revealed.
 |
May 27, 2009 By: George Koroneos, Online Content & News Editor
You know those loud soundtracks and distracting visuals during the safety information in your TV ads? Critics have been complaining about them, and new draft guidance from FDA is calling them a "no-no."
 |
 | May 1, 2009
A five-step blueprint for building a new federal drug and device regulatory agency.
 |
Apr 8, 2009 By:George Koroneos, Online Content & News Editor
FDA is cracking down on content in search engine advertisements. The argument is that there is a serious deficiency of risk information in the tiny link ads that appear on search ads. With pharma already wary of marketing online, will FDA’s tactic hurt future Web campaigns?
 |
Mar 18, 2009 By:Cassandra Blohowiak, contributing editor
The latest state-level attempt to regulate pharma marketing is also the most stringent, requiring both drug and device manufacturers to track and disclose marketing spend. And the state's very important biotech industry is crying foul.
 |
|